SCHEMBL19909212

SCHEMBL19909212

Cc1nc(C)nc(-c2ccc3c(c2)c2cc(-c4nc(C)nc(C)n4)ccc2n3-c2cc(-c3cc(-c4ccccc4)nc(-c4ccccc4)c3)cc(-n3c4ccc(-c5nc(C)nc(C)n5)cc4c4cc(-c5nc(C)nc(C)n5)ccc43)c2C#N)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.40
ADORA1 P30542 7/20 0.40
ADORA2A P29274 6/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
PPARG P37231 1/20 0.40
NCOA2 Q15596 1/20 0.40
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
ALDH1A1 P00352 2/20 0.39
SQOR Q9Y6N5 4/20 0.38
MAPK1 P28482 1/20 0.36
MYC P01106 1/20 0.36
KMT2A Q03164 3/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909214 0.97 SQOR (0.38) L3MBTL1ADORA1ADORA2AKDM4EHPGD
SCHEMBL22563678 0.94 L3MBTL1 (0.41) L3MBTL1ADORA1ADORA2AKDM4EHPGD
SCHEMBL21278723 0.94 L3MBTL1 (0.40) L3MBTL1ADORA1ADORA2AKDM4EHPGD
SCHEMBL22563681 0.92 SQOR (0.39) L3MBTL1ADORA1ADORA2AKDM4EHPGD
SCHEMBL19909548 0.91 MEN1 (0.40) L3MBTL1ADORA1ADORA2AKDM4EHPGD
SCHEMBL21278722 0.91 SQOR (0.38) L3MBTL1ADORA1ADORA2AKDM4EHPGD
SCHEMBL19943078 0.90 L3MBTL1 (0.44) L3MBTL1ADORA1ADORA2AKDM4EHPGD
SCHEMBL19909547 0.88 SQOR (0.38) L3MBTL1ADORA1ADORA2AKDM4EHPGD
SCHEMBL19908979 0.87 MYC (0.43) L3MBTL1ADORA1ADORA2AKDM4EHPGD
SCHEMBL19943075 0.87 L3MBTL1 (0.41) L3MBTL1ADORA1ADORA2AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 L3MBTL1 4685/4885ADORA1 4379/4885ADORA2A 3726/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 L3MBTL1 3886/4885ADORA1 4641/4885ADORA2A 4758/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 L3MBTL1 4685/4885ADORA1 4379/4885ADORA2A 3726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.